A Multicenter, Open-label, Randomized Controlled Trial Evaluating the Efficacy and Safety of Romiplostim N01 in the Treatment of Thrombocytopenia Associated With Concurrent/Sequential Chemoradiotherapy and Chemotherapy Combined With/Without Immunotherapy in Solid Tumors

Clinical trial NCT07185893 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07185893
Sponsor: Jun wang
Status: NOT_YET_RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Solid Tumor Malignancies, Cancer CTIT-Chemotherapy Induced Thrombocytopenia Thrombocytopenia

Start date: 2025-09-01
Primary completion: 2028-03-01
Enrollment: 106

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.